SHW:NYSESherwin-Williams Company (The) Analysis
Data as of 2026-08-22 - not real-time
$346.59
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The Sherwin-Williams Company trades at $346.59, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 3.8%. RSI sits at 49.1, which reads as neutral, and MACD momentum is bearish. Watch $320.00 as support and $372.16 as the nearer resistance level.
Multiples put this in overvalued territory at a P/E of 31.9. Consensus targets land 12.7% above where the shares trade now. Revenue is growing at 7.5% on a 11.0% profit margin. The 0.92% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 38.2%, a beta of 0.82 and a maximum drawdown of 21.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Multiples put this in overvalued territory at a P/E of 31.9. Consensus targets land 12.7% above where the shares trade now. Revenue is growing at 7.5% on a 11.0% profit margin. The 0.92% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 38.2%, a beta of 0.82 and a maximum drawdown of 21.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
Shares of paint and coating manufacturer Sherwin-Williams NYSE:SHW jumped 7.Sherwin-Williams recently reported its second-quarter 2026 results, with sales rising to US$6,789.Sherwin-Williams SHW came out with quarterly earnings of $3.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 334.07
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 334.07
- Analyst targets imply +12.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +12.7% versus the current price
- P/E ratio of 31.9
- Return on equity of 65.1%
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin11.01%
P/E Ratio31.9
ROE65.12%
ROA9.52%
Debt/Equity389.96
P/B Ratio21.7
Op. Cash Flow$3.9B
Free Cash Flow$2.5B
Technical Analysis
TrendBullish
RSI49.1
Support$320.00
Resistance$372.16
MA 20$354.00
MA 50$339.44
MA 200$334.07
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair Value$120.94
Target Price$390.57
Upside/Downside12.69%
GradeOvervalued
TypeGrowth
Dividend Yield0.92%
Risk Assessment
Beta0.82
Volatility38.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.